Celltrion Pharm Inc (068760) - Total Liabilities

Latest as of September 2025: ₩319.38 Billion KRW ≈ $216.44 Million USD

Based on the latest financial reports, Celltrion Pharm Inc (068760) has total liabilities worth ₩319.38 Billion KRW (≈ $216.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Celltrion Pharm Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how Celltrion Pharm Inc's total liabilities have evolved over time, based on quarterly financial data. See Celltrion Pharm Inc (068760) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Celltrion Pharm Inc Competitors by Total Liabilities

The table below lists competitors of Celltrion Pharm Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Treehouse Foods Inc NYSE:THS	USA	$2.51 Billion
Biotage AB ST:BIOT	Sweden	Skr862.00 Million
Grupo Televisa S.A.B. F:TLV	Germany	€122.08 Billion
Dogan Sirketler Grubu Holding AS IS:DOHOL	Turkey	TL78.46 Billion
Sino Medical Sciences Technology In SHG:688108	China	CN¥263.39 Million
United Corporations Limited TO:UNC	Canada	CA$122.62 Million
Tourmaline Bio Inc. NASDAQ:TRML	USA	$10.10 Million
Changzhou Tronly New Electronic Materials Co Ltd SHE:300429	China	CN¥1.55 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Celltrion Pharm Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Celltrion Pharm Inc (068760) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.75	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Celltrion Pharm Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Celltrion Pharm Inc (2011–2024)

The table below shows the annual total liabilities of Celltrion Pharm Inc from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩272.54 Billion ≈ $184.70 Million	+2.85%
2023-12-31	₩264.98 Billion ≈ $179.57 Million	+9.07%
2022-12-31	₩242.94 Billion ≈ $164.64 Million	-20.59%
2021-12-31	₩305.92 Billion ≈ $207.31 Million	+23.60%
2020-12-31	₩247.51 Billion ≈ $167.74 Million	+29.62%
2019-12-31	₩190.95 Billion ≈ $129.40 Million	+4.68%
2018-12-31	₩182.41 Billion ≈ $123.62 Million	+3.26%
2017-12-31	₩176.65 Billion ≈ $119.71 Million	+6.82%
2016-12-31	₩165.37 Billion ≈ $112.07 Million	-28.27%
2015-12-31	₩230.54 Billion ≈ $156.23 Million	+17.18%
2014-12-31	₩196.74 Billion ≈ $133.33 Million	+1.97%
2013-12-31	₩192.94 Billion ≈ $130.75 Million	+11.01%
2012-12-31	₩173.80 Billion ≈ $117.78 Million	+97.92%
2011-12-31	₩87.81 Billion ≈ $59.51 Million	--

About Celltrion Pharm Inc

KQ:068760 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$1.23 Billion

₩1.82 Trillion KRW

Market Cap Rank

#8171 Global

#216 in Korea

Share Price

₩41900.00

Change (1 day)

-3.23%

52-Week Range

₩40500.00 - ₩75700.00

All Time High

₩222138.48